Dividend29 May 2026, 09:22 pm
Concord Biotech Recommends ₹7.55 Dividend for FY26
AI Summary
The Board of Directors of Concord Biotech Ltd has recommended a dividend of ₹7.55 per equity share with a face value of ₹1 each, fully paid up, for the financial year 2025-26, subject to shareholder approval at the upcoming AGM. The record date for dividend payment is fixed as July 24, 2026. The board also approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026, along with the Director's report. Additionally, the board approved the appointment of internal and cost auditors for the F.Y. 2026-27 and appointed Mrs. Ekta Gupta as an Additional Independent Director.
Key Highlights
- Concord Biotech recommends a dividend of ₹7.55 per share for FY26.
- Record date for dividend payment is set as July 24, 2026.
- Audited financial results for Q4 and FY26 were approved.
- M/s. Manubhai & Shah LLP appointed as Internal Auditor for F.Y. 2026-27.
- Mrs. Ekta Gupta appointed as Additional Independent Director.
Price Impact
More from CONCORDBIO